Zotefoams (LON:ZTF - Get Free Report)'s stock had its "buy" rating reissued by equities researchers at Berenberg Bank in a research note issued to investors on Tuesday,Digital Look reports. They presently have a GBX 540 price objective on the stock. Berenberg Bank's price objective indicates a potential upside of 25.00% from the stock's previous close.
Zotefoams Trading Down 0.9%
LON:ZTF opened at GBX 432 on Tuesday. Zotefoams has a 12 month low of GBX 222 and a 12 month high of GBX 485. The company has a quick ratio of 0.67, a current ratio of 1.30 and a debt-to-equity ratio of 42.07. The firm has a market cap of £207.78 million, a price-to-earnings ratio of 20.91, a P/E/G ratio of 0.66 and a beta of 1.40. The company's 50 day moving average is GBX 339.17 and its 200-day moving average is GBX 297.84.
Zotefoams (LON:ZTF - Get Free Report) last announced its earnings results on Tuesday, August 5th. The company reported GBX 19.99 earnings per share (EPS) for the quarter. Zotefoams had a net margin of 7.45% and a return on equity of 8.42%.
Zotefoams Company Profile
(
Get Free Report)
Zotefoams plc, together with its subsidiaries, manufactures, distributes, and sells polyolefin block foams in the United Kingdom, rest of Europe, North America, and internationally. The company operates through Polyolefin Foams, High-Performance Products, and MuCell Extrusion LLC segments. It offers AZOTE, a polyolefin foam under the Plastazote, Evazote, and Supazote, AZOTE Adapt brands; and various high-performance foams manufactured from fluoropolymers, engineering polymers, and specialty elastomers under the ZOTEK brand; and Ecozote foam for plastic products that offers circularity and reduce reliance on fossil fuel-derived raw materials.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Zotefoams, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zotefoams wasn't on the list.
While Zotefoams currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.